Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report

Heliyon · Elsevier

Аннотация

Publication date: November 2026 Source: Heliyon, Volume 12, Issue 16 Author(s): D. Verhoeven, J.J.T.H. Roelofs, M.L. Hilhorst, A.J. Kwakernaak

Читать у издателя →

Похожие статьи